AMPH Crosses Above Average Analyst Target

by admin | 01/31/2022, 06:37

In recent trading, shares of Amphastar Pharmaceuticals Inc (Symbol: AMPH) have crossed above the average analyst 12-month target price of $25.50, changing hands for $26.06/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: do

Focusing on Nuclear Energy Stocks by Knowledge Resources
Tariff Talk Trumps Wall Street by Knowledge Resources
AI Concerns Spooks Market by Knowledge Resources
Five Stocks to Watch in a Tariff War by Knowledge Resources
Alibaba (BABA) Surges as Cloud Growth and Analyst Upgrades Boost Investor Confidence by Knowledge Resources